These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25390773)

  • 1. Optical coherence tomography findings in hydroxychloroquine and chloroquine-associated maculopathy.
    Fung AE; Samy CN; Rosenfeld PJ
    Retin Cases Brief Rep; 2007; 1(3):128-30. PubMed ID: 25390773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
    Wei LC; Chen SN; Ho CL; Kuo YH; Ho JD
    Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal imaging in a severe case of hydroxychloroquine toxicity.
    Bhavsar KV; Mukkamala LK; Freund KB
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):377-9. PubMed ID: 25856825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
    Kahn JB; Haberman ID; Reddy S
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography in a patient with chloroquine-induced maculopathy.
    Korah S; Kuriakose T
    Indian J Ophthalmol; 2008; 56(6):511-3. PubMed ID: 18974527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography in hydroxychloroquine retinopathy: two observational case reports.
    Fontaine F; Rougier MB; Korobelnik JF
    Retin Cases Brief Rep; 2007; 1(3):131-3. PubMed ID: 25390774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine retinopathy after short-term therapy.
    Phillips BN; Chun DW
    Retin Cases Brief Rep; 2014; 8(1):67-9. PubMed ID: 25372212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report.
    Ameen Ismail A; Sadek SH; Hatata RM
    BMC Ophthalmol; 2022 Nov; 22(1):434. PubMed ID: 36376841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive optical coherence tomography deterioration in chloroquine maculopathy.
    Bergstrom C; Garcia-Valenzuela E
    Retin Cases Brief Rep; 2009; 3(2):183-5. PubMed ID: 25391070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chloroquine-induced bull's eye maculopathy without electrophysiologic changes].
    Cursiefen C; Grunert U; Jünemann A
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):400-1. PubMed ID: 9333669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimalarial drug retinopathy].
    Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
    Rev Med Interne; 2018 May; 39(5):364-368. PubMed ID: 29496271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine retinopathy combined with retinal pigment epithelium detachment.
    Lee WJ; Ko MK; Lee BR
    Cutan Ocul Toxicol; 2012 Jun; 31(2):144-7. PubMed ID: 22050195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methoxsalen-induced advanced bull's eye maculopathy.
    Ranjan R; Manayath GJ; Salian R; Narendran V
    Eur J Ophthalmol; 2021 May; 31(3):NP70-NP73. PubMed ID: 32064940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of fundus autofluorescence, spectral-domain optical coherence tomography, and microperimetry in late deferoxamine maculopathy.
    Koinzer S; Klettner A; Treumer F; Nölle B; Roider J
    Retin Cases Brief Rep; 2012; 6(1):50-5. PubMed ID: 25390711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinal pigment epithelium--the point about safety of antimalarial agents].
    Vanheesbeke A
    Bull Soc Belge Ophtalmol; 2007; (304):47-58. PubMed ID: 17718227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F; Marmor MF
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine-induced bull's eye maculopathy.
    Lai WW; Lam DS
    Hong Kong Med J; 2005 Feb; 11(1):55-7. PubMed ID: 15687518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Rodríguez-Hurtado FJ; Sáez-Moreno JA; Rodríguez-Ferrer JM
    Reumatol Clin; 2012; 8(5):280-3. PubMed ID: 22481059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.